Global surveillance network for gonococcal antimicrobial susceptibility

No Thumbnail Available
Cite
Pan American Health Organization. (1990). Global surveillance network for gonococcal antimicrobial susceptibility [Journal articles]. https://iris.paho.org/handle/10665.2/44534
Date
1990
Document Number
WHO/VDT/90.452. Unpublished
ISBN
eISBN
ISSN
DOI
Other Language Versions
Description
Notes
Pages
Volume
Replaces
Table of contents
Link to WHO's original document
Series
Link to WHO's original document
Category
Youtube URI
Citation
Status Mendates
License

Related items

Showing items related by metadata.

  • Item
    Desigualdades sociales relacionadas con la resistencia a antimicrobianos de N. gonorrhoeae en Colombia
    (2020) Rivillas-García, Juan Carlos; Sanchez, Sandra Marcela; Rivera-Montero, Danny
    [RESUMEN]. Objetivo. Medir desigualdades sociales en la resistencia antimicrobiana de la Neisseria gonorrhoeae en Colombia. Métodos. Estudio ecológico utilizando un multipanel de datos desagregado a nivel subnacional de los aislamientos en la N. gonorrhoeae como proxy de resistencia antimicrobiana (RAM) entre 2009 y 2018. Se llevó a cabo una caracterización sociodemográfica, un análisis de la sensibilidad antimicrobiana de aislamientos de N. gonorrhoeae, y una medición de desigualdades en la RAM para la N. gonorrhoeae mediante el índice de desigualdad de la pendiente, el índice de desigualdad relativo y el índice de concentración. Resultados. Los hallazgos indican resistencia antimicrobiana de aislamientos de N. gonorrhoeae a penicilina (50,7%) y tetraciclina (67,3%); y la existencia de desigualdades absolutas y relativas durante el período analizado. Las barreras de acceso a servicios de salud, no haber recibido información de prevención de las infecciones de transmisión sexual, necesidades básicas insatisfechas y analfabetismo explicaron las desigualdades en la RAM de la N. gonorrhoeae. Conclusiones. Seis recomendaciones emergen para contener en gran medida la RAM en la N. gonorrhoeae: i) aumentar conciencia sobre la salud sexual y reproductiva segura; ii) repensar cómo entregar mensajes claves con enfoque de equidad; iii) mejorar los sistemas de información, prescripción y cadena de medicamentos; iv) crear coaliciones para mejorar la respuesta y compartir objetivos con el sector privado; v) mejorar la disponibilidad y desagregación de los datos; y vi) apoyar investigaciones en desigualdades en RAM.
  • Item
    Neisseria gonorrhoeae Antimicrobial Resistance Surveillance: Consolidated Guidance
    (PAHO, 2020) Pan American Health Organization
    Prevention, early diagnosis, and effective treatment are essential for the control and elimination of Neisseria gonorrhoeae as a public health problem. Currently, in Latin America and the Caribbean, treatment for gonorrhea infection is largely empiric and based on clinical diagnosis. In the Americas, the high burden of new N. gonorrhoeae infections (estimated at 11 million new cases a year), the complexity of the disease epidemiology, and in many countries the limited resources, make it difficult to fully understand the burden of disease and the burden of antimicrobial resistance (AMR) in N. gonorrhoeae. PAHO has developed this document to facilitate the navigation of available guidance and recommendations for N. gonorrhoeae AMR surveillance by public health and health care professionals, at the national and subnational levels, involved in designing, implementing, and/or strengthening AMR surveillance of N. gonorrhoeae and overall surveillance of sexually transmitted infections. This document aims to consolidate guidance on AMR surveillance for N. gonorrhoeae from documents published by WHO and PAHO, and strives to assemble relevant information in a summarized manner to help countries in strengthening and/or developing AMR surveillance systems for N. gonorrhoeae.
  • Item
    Whole-genome sequencing for surveillance of antimicrobial resistance in Ecuador: present and future implications
    (2023) Calero-Cáceres, William
    [ABSTRACT]. Whole-genome sequencing is becoming the gold standard for pathogen characterization and offers consid- erable advantages for understanding the evolution and dissemination of new determinants of antimicrobial resistance. Despite the benefits of whole-genome sequencing for pathogen characterization, implementation costs and lack of expertise may limit its use by public health laboratories. This article reviews the advantages of whole-genome sequencing for pathogen characterization and the current status of the use of whole-ge- nome sequencing for antimicrobial resistance surveillance in Ecuador. A roadmap is suggested for including whole-genome sequencing for pathogen characterization based on the needs of the health reference insti- tutions through alliances with Ecuadorian universities. Establishing a partnership between public health institutions and academia would be valuable for clinicians, policy-makers, and epidemiologists who could then take reasonable measures in those areas and establish a basis for adapting One Health strategies to tackle antimicrobial resistance in Ecuador.
  • Item
    Global distribution of B-lactamase-producing neisseria gonorrhoeae
    (1981) Pan American Health Organization
  • Item
    Surveillance of antimicrobial resistance of Streptococcus pneumoniae and Haemophilus influenzae : Report of a Meeting
    (1991) Pan American Health Organization; World Health Organization
    Meeting on Surveillance of Antimicrobial Resistance of Streptococcus Pneumoniae and Haemophilus Influenzae. World Health Organization; 10-13 Dec. 1990